Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Carbogen Amcis Adds High-Potency Plant
by Rick Mullin
August 11, 2014
| A version of this story appeared in
Volume 92, Issue 32
The Swiss fine chemicals firm Carbogen Amcis has agreed to take over a high-containment facility formerly managed by peptides specialist Bachem. The plant, in Vionnaz, Switzerland, opened in 2005 to manufacture highly potent pharmaceutical chemicals in quantities ranging from grams to kilograms. “We are facing a significant increase in the demand for high-potency services, spurred by the fast-paced growth of the antibody-drug conjugates market,” says Carbogen CEO Mark C. Griffiths.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter